Dr. Christopher Allan King is a Dover, New Hampshire based Oral and Maxillofacial Surgeon who is specialized in Oral and Maxillofacial Surgery. He may accept the Medicare-approved amount. Patients may be billed for more than the Medicare deductible and coinsurance. His current practice location is 801 Central Ave, Suite 1, Dover. Patients can reach him at 603-842-4222.
Dr. Christopher Allan King deals with the diagnosis, surgical and adjunctive treatment of diseases, injuries and defects involving both the functional and esthetic aspects of the hard and soft tissues of the oral and maxillofacial region.
Complete Profile:
Dr. Christopher Allan King speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Name:
Dr. Christopher Allan King
Specialization:
Oral and Maxillofacial Surgeon
Gender:
Male
Credentials:
DMD
Accepts Medicare Assignment:
May Accept
Practice Address:
801 Central Ave, Suite 1, Dover, New Hampshire, 03820-2529
Phone:
603-842-4222
Fax:
603-343-5672
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
PAC ID:
1658527882
Enrollment ID:
I20130829000016
NPI Number:
1790949261
NPI Enumeration Date:
15 Jul, 2008
NPI Last Update On:
28 Apr, 2016
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
801 Central Ave, Suite 1 Dover, New Hampshire
Zip:
03820-2529
Phone Number:
603-842-4222
Fax Number:
603-343-5672
Patients can reach Dr. Christopher Allan King at 801 Central Ave, Suite 1, Dover, New Hampshire or can call to book an appointment on 603-842-4222. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 December, 2024.